April 2025
1. UM JH, Zheng Y, Mao Q, Nam C, et al
   Genomic and Single-Cell Analyses Characterize Patient-Derived Tumor Organoids to Enable Personalized Therapy for Head and Neck Squamous Cell Carcinoma.
   Cancer Res. 2025 Apr 22. doi: 10.1158/0008-5472.CAN-24-2850.
   

   >> Share

   
   
2. ZHAN J, Li M, Li L, Zeng TT, et al
   Targeting LTBP2 Derived from Cancer-Associated Fibroblasts Sensitizes Esophageal Squamous Cell Carcinoma to Chemotherapy.
   Cancer Res. 2025 Apr 17. doi: 10.1158/0008-5472.CAN-24-1816.
   

   >> Share

   
   
3. NIU S, Ma J, Liu S, Li Y, et al
   Cis-regulatory Alterations in FOXP4 Modulate Esophageal Cancer Susceptibility Induced by Chronic Alcohol Exposure.
   Cancer Res. 2025 Apr 14. doi: 10.1158/0008-5472.CAN-24-3839.
   

   >> Share

   
   
4. MENG L, Wu H, Wu J, Ding P, et al
   Aberrant CircTMEM45A Facilitates Inflammatory Progression of Esophageal Squamous Cell Carcinoma through m5C-Mediated NLRP3 Activation.
   Cancer Res. 2025 Apr 11. doi: 10.1158/0008-5472.CAN-24-4154.
   

   >> Share

   
   December 2024
5. OU Z, Zhu L, Chen X, Liu T, et al
   Hypoxia-Induced Senescent Fibroblasts Secrete IGF1 to Promote Cancer Stemness in Esophageal Squamous Cell Carcinoma.
   Cancer Res. 2024 Dec 11. doi: 10.1158/0008-5472.CAN-24-1185.
   

   >> Share

   
   November 2024
6. ZHANG J, Ni Z, Zhang Y, Guo Y, et al
   DAZAP1 Phase Separation Regulates Mitochondrial Metabolism to Facilitate Invasion and Metastasis of Oral Squamous Cell Carcinoma.
   Cancer Res. 2024;84:3818-3833.
   

   >> Share

   
   
7. PLITT G, Brewer T, Yehia L, Rabinowitz L, et al
   The Genomic Landscape of Benign and Malignant Thyroid Tumors from Individuals Carrying Germline PTEN Variants Is Distinct from Sporadic Thyroid Cancers.
   Cancer Res. 2024;84:3657-3668.
   

   >> Share

   
   August 2024
8. ZHOU L, Tian J, Wang K, Ma Y, et al
   Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma.
   Cancer Res. 2024 Aug 26. doi: 10.1158/0008-5472.CAN-23-2241.
   

   >> Share

   
   July 2024
9. YANG J, Chen F, Lang L, Yang F, et al
   Therapeutic Targeting of the GLS1-c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer.
   Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-24-0254.
   

   >> Share

   
   
10. GNANAPRAGASAM A, Kirbizakis E, Li A, White KH, et al
    HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer.
    Cancer Res. 2024;84:2377-2389.
    

    >> Share

    
    
11. DIAO P, Dai Y, Wang A, Bu X, et al
    Integrative multi-omics analyses identify molecular subtypes of head and neck squamous cell carcinoma with distinct therapeutic vulnerabilities.
    Cancer Res. 2024 Jul 3. doi: 10.1158/0008-5472.CAN-23-3594.
    

    >> Share

    
    
12. LI B, Hao Y, He H, Fan Y, et al
    CD47-SIRPalpha Blockade Sensitizes Head and Neck Squamous Cell Carcinoma to Cetuximab by Enhancing Macrophage Adhesion to Cancer Cells.
    Cancer Res. 2024 Jul 3. doi: 10.1158/0008-5472.CAN-24-0176.
    

    >> Share

    
    May 2024
13. BAKER AM, Nageswaran G, Nenclares P, Ronel T, et al
    FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA.
    Cancer Res. 2024;84:1560-1569.
    

    >> Share

    
    
14. MENG X, Zheng Y, Zhang L, Liu P, et al
    Single-cell analyses reveal the metabolic heterogeneity and plasticity of the tumor microenvironment during head and neck squamous cell carcinoma progression.
    Cancer Res. 2024 May 8. doi: 10.1158/0008-5472.CAN-23-1344.
    

    >> Share

    
    January 2024
15. LI C, Guo H, Zhai P, Yan M, et al
    Spatial and Single-Cell Transcriptomics Reveal a Cancer-Associated Fibroblast Subset in HNSCC That Restricts Infiltration and Antitumor Activity of CD8+ T Cells.
    Cancer Res. 2024;84:258-275.
    

    >> Share

    
    December 2023
16. SHI Q, Xu G, Jiang Y, Yang J, et al
    Phospholipase PLCE1 promotes transcription and phosphorylation of MCM7 to drive tumor progression in esophageal cancer.
    Cancer Res. 2023 Dec 20. doi: 10.1158/0008-5472.CAN-23-1633.
    

    >> Share

    
    October 2023
17. SMITH AE, Chan S, Wang Z, McCloskey A, et al
    Tipifarnib Potentiates the Antitumor Effects of PI3Kalpha Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.
    Cancer Res. 2023;83:3252-3263.
    

    >> Share

    
    
18. LEE RH, Johnson DE, Grandis JR
    To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck Cancer.
    Cancer Res. 2023;83:3162-3164.
    

    >> Share

    
    September 2023
19. SFANOS KS
    Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response.
    Cancer Res. 2023;83:2985-2986.
    

    >> Share

    
    
20. ARBORE G, Albarello L, Bucci G, Punta M, et al
    Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma.
    Cancer Res. 2023;83:2873-2888.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share